Comparison of Fever-reducing Effects in Self-reported Data from the Mobile App: Antipyretic Drugs in Pediatric Patients
- PMID: 32127557
- PMCID: PMC7054323
- DOI: 10.1038/s41598-020-60193-1
Comparison of Fever-reducing Effects in Self-reported Data from the Mobile App: Antipyretic Drugs in Pediatric Patients
Erratum in
-
Publisher Correction: Comparison of Fever-reducing Effects in Self-reported Data from the Mobile App: Antipyretic Drugs in Pediatric Patients.Sci Rep. 2020 May 12;10(1):8071. doi: 10.1038/s41598-020-64762-2. Sci Rep. 2020. PMID: 32398714 Free PMC article.
Abstract
We compared the fever-reducing efficacy of acetaminophen (AA), ibuprofen (IBU), and dexibuprofen (DEX) using data collected from the mobile healthcare application FeverCoach, which provides parents with guidelines for determining their child's health condition, according to body temperature. Its dataset includes 4.4 million body temperature measurement records and 1.6 million antipyretics treatment records. Changes in body temperature over time were compared after taking one of three different antipyretics (AA, IBU, and DEX), using a one-way ANOVA followed by a post-hoc analysis. A multivariate linear model was used to further analyze the average body temperature differences, calibrating for the influences of age, weight, and sex. Children administered IBU had average body temperatures that were 0.18 °C (0.17-0.19 °C), 0.25 °C (0.24-0.26 °C), and 0.18 °C (0.17-0.20 °C) lower than those of children administered AA, at time intervals of 1-2 hours, 2-3 hours, and 3-4 hours, respectively. Similarly, children administered DEX had average body temperatures that were 0.24 °C (0.24-0.25 °C), 0.28 °C (0.27-0.29 °C), and 0.12 °C (0.10-0.13 °C) lower than those of children administered AA, at time intervals of 1-2, 2-3, and 3-4 hours, respectively. Although the data were collected from the application by non-professional parents, the analysis showed that IBU and DEX were more effective in reducing body temperature than AA was.
Conflict of interest statement
Jiyun Choi is a researcher and Seyun Chang is the CTO of Mobile Doctor Co., Ltd., which manufactured the “FeverCoach” app. Jong Gyun Ahn has no conflict of interest to disclose. No funding was received for conducting this study.
Figures
Similar articles
-
Postvaccination Fever Response Rates in Children Derived Using the Fever Coach Mobile App: A Retrospective Observational Study.JMIR Mhealth Uhealth. 2019 Apr 22;7(4):e12223. doi: 10.2196/12223. JMIR Mhealth Uhealth. 2019. PMID: 31008712 Free PMC article.
-
Determinants of antipyretic misuse in children up to 5 years of age: a cross-sectional study.Clin Ther. 2006 May;28(5):783-93. doi: 10.1016/j.clinthera.2006.05.010. Clin Ther. 2006. PMID: 16861100
-
Combined and alternating paracetamol and ibuprofen therapy for febrile children.Evid Based Child Health. 2014 Sep;9(3):675-729. doi: 10.1002/ebch.1978. Evid Based Child Health. 2014. PMID: 25236309 Review.
-
The antipyretic efficacy and safety of propacetamol compared with dexibuprofen in febrile children: a multicenter, randomized, double-blind, comparative, phase 3 clinical trial.BMC Pediatr. 2018 Jun 23;18(1):201. doi: 10.1186/s12887-018-1166-z. BMC Pediatr. 2018. PMID: 29935535 Free PMC article. Clinical Trial.
-
Treating fever in children: paracetamol or ibuprofen?Br J Community Nurs. 2002 Jun;7(6):316-20. doi: 10.12968/bjcn.2002.7.6.10477. Br J Community Nurs. 2002. PMID: 12066066 Review.
References
-
- Kluger, M. J. Fever, its biology, evolution, and function. (Princeton University Press, 1979).
LinkOut - more resources
Full Text Sources